Iqvia Holdings Inc. (IQV): Share Repurchases
$1.24B
Year ended 2025-12-31
$1.42B
Trailing 12 months to 2026-03-31
+2.1%
3-year compound annual growth
+22.7%
5-year compound annual growth
+9.2%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.24B | -7.9% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $1.35B | +36.1% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $992.00M | -15.1% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $1.17B | +187.7% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $406.00M | -9.2% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $447.00M | -52.9% | 2023-02-15, From 2020-01-01 |
| 2019-12-31 | $949.00M | -32.5% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $1.41B | -46.4% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $2.62B | +138.8% | 2020-02-18, From 2017-01-01 |
| 2016-12-31 | $1.10B | +113.0% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $515.00M | +24.1% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $415.00M | n/m | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $6.43M | -51.9% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $13.36M | -6.7% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $14.32M | n/a | 2014-02-13, From 2011-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.24B | -7.9% |
| Icon PLC (ICLR) | 2025-12-31 | $750.00M | +50.0% |
| Incyte Corp (INCY) | 2025-12-31 | $0 | -100.0% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $360.67M | +202.6% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $917.39M | +440.1% |
| NRC Health (NRC) | 2025-12-31 | $20.18M | -34.8% |
| IB Acquisition Corp. (IBAC) | 2025-09-30 | $106.13M | n/a |
Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗